China-based Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050), an ophthalmic medical device manufacturer, announced plans for a private placement of 3,593,615 shares at RMB 79.2 (USD 10.9) per share. The proceeds, expected to reach RMB 285 million (USD 39 million), will be used to expand its contact lens production capacity.
Company Background
Eyebright Medtech, driven by innovation, offers a comprehensive product pipeline covering ophthalmic surgery treatment, myopia prevention and control, and visual health care. The company provides one-stop solutions for cataract surgery, refractive error correction, and optical consumption, aiming to meet diverse clinical needs in the ophthalmic sector.-Fineline Info & Tech
Leave a Reply